RT @DrJHK: Relative Efficacy of Systemic Treatments for Patients with Advanced Hepatocellular Carcinoma According to Viral Status: A System…
RT @DrJHK: Relative Efficacy of Systemic Treatments for Patients with Advanced Hepatocellular Carcinoma According to Viral Status: A System…
Relative Efficacy of Systemic Treatments for Patients with Advanced Hepatocellular Carcinoma According to Viral Status: A Systematic Review and Network Meta-Analysis https://t.co/7nTjHFWdLW
RT @Ablate_Cancer: Conclusions Compared with sorafenib, lenvatinib was more efficacious in the HBV subgroup than in the HCV subgroup, and…
Conclusions Compared with sorafenib, lenvatinib was more efficacious in the HBV subgroup than in the HCV subgroup, and the relative ranking of sorafenib in the HBV subgroup was lower than in the HCV subgroup. Each targeted agent reported to be the best...
RT @TargetOncology: Relative Efficacy of Systemic Treatments for Patients with Advanced Hepatocellular Carcinoma According to Viral Status:…
Relative Efficacy of Systemic Treatments for Patients with Advanced Hepatocellular Carcinoma According to Viral Status: A Systematic Review and Network Meta-Analysis #HCC https://t.co/E0h7bhikDQ https://t.co/qhPYCZL9QU